Page last updated: 2024-08-21

thiazolidines and mk 0852

thiazolidines has been researched along with mk 0852 in 15 studies

Research

Studies (15)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	10 (66.67)	18.2507
2000's	5 (33.33)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Larsson, A; Lindahl, TL	1
Holahan, MA; Lynch, JJ; Lynch, RJ; Manno, PD; Mellott, MJ; Ramjit, DR; Sitko, GR; Stabilito, II; Stranieri, MT; Zhang, G	1
Barrish, A; Fernandez-Metzler, C; Gilbert, JD; Hand, EL; Hichens, M; Olah, TV; Yuan, AS	1
Hoylaerts, MF; Stassen, JM; Thys, C; Vermylen, J	1
Heptinstall, S; May, JA; Spangenberg, P	1
Bogusky, MJ; Coddington, AB; Dubost, DC; Kaufman, MJ; Pitzenberger, SM; Zimmerman, JA	1
Rossi, G	1
Rothe, G; Schmitz, G; Wittig, K	1
Bednar, B; Bednar, RA; Egbertson, MS; Gaul, SL; Gould, RJ; Hamill, TG; Hartman, GD; Shafer, JA	1
Heptinstall, S; Storey, RF; Wilcox, RG	1
Barchowsky, A; Barrett, J; Bjornsson, TD; Farrell, D; Gillen, L; Goldberg, MR; Gould, R; Greenberg, HE; Hand, E; Panebianco, D; Wissel, P	1
Bogaty, P; Kingma, JG; Plante, S	1
Lages, B; Weiss, HJ	1
Bath, PM; Fox, S; Heptinstall, S; Judge, H; Lösche, W; May, J; Zhao, L	1
Bath, P; Heptinstall, S; Lösche, W; Zhao, L	1

Trials

2 trial(s) available for thiazolidines and mk 0852

Article	Year
Differential effects of glycoprotein IIb/IIIa antagonists on platelet microaggregate and macroaggregate formation and effect of anticoagulant on antagonist potency. Implications for assay methodology and comparison of different antagonists. Circulation, 1998, Oct-20, Volume: 98, Issue:16 Topics: Adenosine Diphosphate; Anticoagulants; Citrates; Collagen; Eptifibatide; Hirudins; Humans; Nephelometry and Turbidimetry; Oligopeptides; Peptides; Peptides, Cyclic; Piperazines; Piperidines; Platelet Aggregation Inhibitors; Platelet Count; Platelet Glycoprotein GPIIb-IIIa Complex; Sodium Citrate; Thiazolidines	1998
Antiplatelet effects of MK-852, a platelet fibrinogen receptor antagonist, in healthy volunteers. Journal of clinical pharmacology, 2000, Volume: 40, Issue:5 Topics: Adenosine Diphosphate; Adult; Area Under Curve; Collagen; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Infusions, Intravenous; Male; Metabolic Clearance Rate; Oligopeptides; Peptides, Cyclic; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Platelet Glycoprotein GPIIb-IIIa Complex; Thiazolidines; Time Factors	2000

Article

Year

Differential effects of glycoprotein IIb/IIIa antagonists on platelet microaggregate and macroaggregate formation and effect of anticoagulant on antagonist potency. Implications for assay methodology and comparison of different antagonists.

Circulation, 1998, Oct-20, Volume: 98, Issue:16

Topics: Adenosine Diphosphate; Anticoagulants; Citrates; Collagen; Eptifibatide; Hirudins; Humans; Nephelometry and Turbidimetry; Oligopeptides; Peptides; Peptides, Cyclic; Piperazines; Piperidines; Platelet Aggregation Inhibitors; Platelet Count; Platelet Glycoprotein GPIIb-IIIa Complex; Sodium Citrate; Thiazolidines

1998

Antiplatelet effects of MK-852, a platelet fibrinogen receptor antagonist, in healthy volunteers.

Journal of clinical pharmacology, 2000, Volume: 40, Issue:5

Topics: Adenosine Diphosphate; Adult; Area Under Curve; Collagen; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Infusions, Intravenous; Male; Metabolic Clearance Rate; Oligopeptides; Peptides, Cyclic; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Platelet Glycoprotein GPIIb-IIIa Complex; Thiazolidines; Time Factors

2000

Other Studies

13 other study(ies) available for thiazolidines and mk 0852

Article	Year
Inhibition of fibrinogen binding to platelets by MK-852, a new GPIIb/IIIa antagonist. Upsala journal of medical sciences, 1994, Volume: 99, Issue:2 Topics: Animals; Antigen-Antibody Complex; Blood Platelets; Fibrinogen; Flow Cytometry; Humans; Oligopeptides; Peptides, Cyclic; Platelet Membrane Glycoproteins; Rabbits; Thiazolidines	1994
Antithrombotic effects of MK-0852, a platelet fibrinogen receptor antagonist, in canine models of thrombosis. The Journal of pharmacology and experimental therapeutics, 1993, Volume: 266, Issue:3 Topics: Amino Acid Sequence; Animals; Bleeding Time; Blood Platelets; Coronary Circulation; Coronary Thrombosis; Disease Models, Animal; Dogs; Female; Femoral Artery; Fibrinolytic Agents; Kinetics; Male; Molecular Sequence Data; Oligopeptides; Peptides, Cyclic; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Thiazolidines; Thrombosis	1993
Determination of MK-852, a new fibrinogen receptor antagonist, in plasma and urine by radioimmunoassay. Journal of pharmaceutical and biomedical analysis, 1993, Volume: 11, Issue:6 Topics: Amino Acid Sequence; Animals; Blood Proteins; Cross Reactions; Female; Heparin; Humans; Molecular Sequence Data; Oligopeptides; Peptides, Cyclic; Platelet Membrane Glycoproteins; Rabbits; Radioimmunoassay; Reproducibility of Results; Sensitivity and Specificity; Serum Albumin, Bovine; Thiazolidines	1993
Dose-responses to inducers and inhibitors of platelet aggregation analysed via a micro-method. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 1996, Volume: 7, Issue:2 Topics: Adenosine Diphosphate; Animals; Arachidonic Acid; Collagen; Cricetinae; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; Oligopeptides; Peptides, Cyclic; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Count; Platelet Function Tests; Rabbits; Scattering, Radiation; Thiazolidines	1996
Changes in the composition of the platelet cytoskeleton in response to ADP: effects of MK-852 and ARL 66096. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 1996, Volume: 7, Issue:2 Topics: Actinin; Actins; Adenosine Diphosphate; Adenosine Triphosphate; Blood Platelets; Cytoskeletal Proteins; Cytoskeleton; Electrophoresis, Polyacrylamide Gel; Humans; In Vitro Techniques; Microfilament Proteins; Myosins; Oligopeptides; Peptides, Cyclic; Platelet Activation; Platelet Aggregation Inhibitors; Thiazolidines	1996
Characterization of a solid state reaction product from a lyophilized formulation of a cyclic heptapeptide. A novel example of an excipient-induced oxidation. Pharmaceutical research, 1996, Volume: 13, Issue:12 Topics: Benzaldehydes; Drug Stability; Drug Storage; Excipients; Magnetic Resonance Spectroscopy; Oligopeptides; Oxidation-Reduction; Peptides, Cyclic; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thiazolidines	1996
[Superaspirin in the platelet aggregation inhibitor therapy]. Recenti progressi in medicina, 1997, Volume: 88, Issue:12 Topics: Abciximab; Acetates; Antibodies, Monoclonal; Aspirin; Fibrinolytic Agents; Humans; Immunoglobulin Fab Fragments; Integrins; Myocardial Infarction; Oligopeptides; Peptides, Cyclic; Platelet Aggregation Inhibitors; Recurrence; Sulfoxides; Thiazolidines; Time Factors; Tyrosine	1997
Inhibition of fibrinogen binding and surface recruitment of GpIIb/IIIa as dose-dependent effects of the RGD-mimetic MK-852. Thrombosis and haemostasis, 1998, Volume: 79, Issue:3 Topics: Adult; Blood Platelets; Fibrinogen; Humans; Middle Aged; Oligopeptides; Peptides, Cyclic; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Binding; Protein Conformation; Thiazolidines	1998
Identification of low molecular weight GP IIb/IIIa antagonists that bind preferentially to activated platelets. The Journal of pharmacology and experimental therapeutics, 1998, Volume: 285, Issue:3 Topics: Azepines; Binding, Competitive; Blood Platelets; Fibrinolytic Agents; Humans; Intercellular Signaling Peptides and Proteins; Oligopeptides; Peptides; Peptides, Cyclic; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Sulfonamides; Thiazolidines	1998
Platelet GPIIb/IIIa receptor blockade reduces infarct size in a canine model of ischemia-reperfusion. Journal of the American College of Cardiology, 2000, Volume: 36, Issue:7 Topics: Animals; Coronary Circulation; Disease Models, Animal; Dogs; Female; Flow Cytometry; Heart; Hemodynamics; Hyperemia; Male; Myocardial Contraction; Myocardial Infarction; Myocardial Reperfusion Injury; Oligopeptides; Peptides, Cyclic; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thiazolidines	2000
Greater inhibition of platelet procoagulant activity by antibody-derived glycoprotein IIb--IIIa inhibitors than by peptide and peptidomimetic inhibitors. British journal of haematology, 2001, Volume: 113, Issue:1 Topics: Abciximab; Antibodies, Monoclonal; Blood Platelets; Calcium; Cytosol; Enzyme Inhibitors; Eptifibatide; Fura-2; Humans; Immunoglobulin Fab Fragments; Immunoglobulin Fragments; Oligopeptides; Peptides; Peptides, Cyclic; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thiazolidines; Thromboplastin	2001
The effects of GPIIb-IIIa antagonists and a combination of three other antiplatelet agents on platelet-leukocyte interactions. Current medical research and opinion, 2003, Volume: 19, Issue:3 Topics: Abciximab; Adenosine Monophosphate; Antibodies, Monoclonal; Aspirin; Blood Platelets; CD11b Antigen; Dipyridamole; Humans; Immunoglobulin Fab Fragments; In Vitro Techniques; Leukocytes; Monocytes; Neutrophils; Oligopeptides; Peptides, Cyclic; Platelet Glycoprotein GPIIb-IIIa Complex; Thiazolidines; Thromboplastin	2003
Platelet-monocyte interaction and GPIIb/IIIa blockade. Thrombosis and haemostasis, 2004, Volume: 92, Issue:4 Topics: Blood Platelets; Cell Communication; Humans; Monocytes; Oligopeptides; Peptides, Cyclic; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Receptors, Thrombin; Thiazolidines	2004